Skip to main content

New strategy and clear focus

  • Fresenius has hit RESET and is now moving towards #FutureFresenius with a simplified structure, sharper focus and acceleration of performance
  • Intention to deconsolidate Fresenius Medical Care by changing the legal form of FMC to a German Stock Corporation (“Aktiengesellschaft”) in simplified governance
  • Focus on Operating Companies Fresenius Kabi and Fresenius Helios
  • Active portfolio management for assets where Fresenius lacks best ownership
  • New, more rigorous Fresenius Financial Framework with ambitious segment margin bands
  • ~€1bn annual structural productivity improvement by 2025
March 23

March 23, 2023
Bad Homburg, Germany

Annual Report 2022

Consolidated Financial Statements and Management Report (IFRS)


Image Desc.

May 09, 2023
Bad Homburg, Germany

Conference Call Q1 2023, Fresenius

Live Webcast

Next event

Advancing patient care

“This is an inflection point for Fresenius. The new structure will greatly benefit both companies: FMC needs an operational turnaround, to improve its performance and focus on its core business. Fresenius needs to simplify its complex corporate structures and commit to its Operating Companies and to maximizing value from its investments.

Michael Sen, Chairman of the Management Board

Non-financial and Sustainability Reporting

We are committed to being a socially and environmentally responsible corporate player in the global healthcare market. We have the ambition to shape future healthcare and build a sound base for sustainable growth.



Social Media

By clicking “I consent” you consent to the activation of the activity feed on this website and the following processing of your personal data related to it according to Section 2 of the Privacy Statement